Evidence map›Paper›PMID 36553458›Full record

ArticleGenes2022

A

René G Feichtinger, Martin Preisel, Katja Steinbrücker, Karin Brugger, Alexandra Radda, Saskia B Wortmann, Johannes A Mayr

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

René G FeichtingerDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.ORCID 0000-0002-4215-8258
Martin PreiselDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Katja SteinbrückerDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Karin BruggerDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.ORCID 0000-0002-6440-1036
Alexandra RaddaDepartment of Pediatrics, Hospital Villach, 9500 Villach, Austria.
Saskia B WortmannDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Johannes A MayrDepartment of Pediatrics, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.ORCID 0000-0001-6970-336X
Paracelsus Medical University · ATRadboud University Nijmegen · NLTechnikon (Austria) · AT

Funding

Austrian Science Fund FWF I 4695
6 · The paper itself

Abstract

Heterozygous deletions at 19q12-q13.11 affecting TSHZ3, the teashirt zinc finger homeobox 3, have been associated with intellectual disability and behavioural issues, congenital anomalies of the kidney and urinary tract (CAKUT), and postnatal growth retardation in humans and mice.

Indexed as

Intellectual DisabilityKidney DiseasesVesico-Ureteral RefluxAbnormalities, MultipleAnimalsChildChromosome DeletionChromosome DisordersFemaleHomeodomain ProteinsHumansMiceTranscription FactorsUrogenital AbnormalitiesHomeodomain ProteinsTranscription FactorsTSHZ3 protein, humanneurodevelopmental disordernovel disease locirenal disorderTSHZ3

Identifiers

PMID36553458
PMCPMC9778592
OpenAlexW4309845442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.